Yabao Pharmaceutical Group Co., Ltd (SHA:600351)

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceutical Production - Pediatrics	901.17M
Pharmaceutical Production - Pediatrics Growth	47.83%
Pharmaceutical Production - Cardiovascular System	774.75M
Pharmaceutical Production - Cardiovascular System Growth	-2.91%
Pharmaceutical Wholesale	433.29M
Pharmaceutical Wholesale Growth	1.45%
Pharmaceutical Production - Other	164.78M
Pharmaceutical Production - Other Growth	5.81%
Pharmaceutical Production - Raw Materials	142.54M
Pharmaceutical Production - Raw Materials Growth	25.28%
Pharmaceutical Production - Psychiatry and Neurology	112.57M
Pharmaceutical Production - Psychiatry and Neurology Growth	-25.15%
Pharmaceutical Production - Endocrine System	99.50M
Pharmaceutical Production - Pain Relief	78.73M
Pharmaceutical Production - Pain Relief Growth	-60.06%
Pharmaceutical Production - Digestive System	78.70M
Pharmaceutical Production - Digestive System Growth	-0.91%
Other	123.74M
Other Growth	6.19%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	2.91B
China Growth	7.05%